Listeriosis in patients at a comprehensive cancer center, 1955-1997

Clinical Infectious Diseases

Volumn 37, Issue 3, 2003, Pages 359-364

  Safdar, Amar ^a,b   Armstrong, Donald ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BRAIN INFECTION; BREAST CARCINOMA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEROTYPE; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MALE; MIDDLE AGED; NEOPLASMS; PREGNANCY; RETROSPECTIVE STUDIES; SEROTYPING; TREATMENT OUTCOME;

EID: 0043162154     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/376631     Document Type: Article

References (34)

1. Safdar A, Armstrong D. Infectious morbidity in critically ill patient with cancer. Crit Care Clin 2001; 17:531-70.
2. Lorber B. Listeriosis. Clin Infect Dis 1997; 24:1-11.
3. Louria DB, Hensle T, Armstrong D, et al. Listeriosis complicating malignant disease: a new association. Ann Intern Med 1967; 67:261-81.
4. Lorber B. Listeria monocytogenes. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:2208-15.
5. Mackaness GB. Resistance to intracellular infections. J Infect Dis 1971; 123:439-45.
6. Kwok LY, Miletic H, Lutjen S, Soltek S, Deckert M, Schluter D. Protective immunosurveillance of the central nervous system by Listeria-specific CD4 and CD8 T cells in systemic listeriosis in the absence of intracerebral Listeria. J Immunol 2002; 169:2010-9.
7. Portnoy DA, Auerbuch V, Glomski IJ. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J Cell Biol 2002; 158:409-14.
8. Jurado RL, Farley MM, Pereira E, et al. Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. Clin Infect Dis 1993; 17:224-7.
9. Aureli P, Fiorucci GC, Caroli D, et al. An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N Engl J Med 2000; 342:1236-41.
10. Broome CV. Listeriosis: can we prevent it? ASM News 1993; 59:444-6.
11. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U. S. Public Health Service and the Infectious Disease Society of America. MMWR Recomm Rep 2002; 51(RR-8):1-52.
12. Tappero JW, Schuchat A, Deaver KA, Mascola L, Wenger JD. Reduction in the incidence of human listeriosis in the United States: effectiveness of prevention efforts? Listeriosis Study Group. JAMA 1995; 273:1118-22.
13. Safdar A, Papadopoulous EB, Armstrong D. Listeriosis in recipients of allogeneic blood and marrow transplantation: thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection. Bone Marrow Transplant 2002; 29:913-6.
14. Mora J, White M, Dunkel IJ. Listeriosis in pediatric oncology patients. Cancer 1998; 83:817-20.
15. Seelinger HPR, Hohne K. Listeria monocytogenes and related species. In: Bergan T, Norris JR, eds. Methods of microbiology. London: Academic Press, 1979:31-49.
16. Raybourne RB. Virulence testing of Listeria monocytogenes. J AOAC Int 2002; 85:516-23.
17. Dussurget O, Cabanes D, Dehoux P, et al. Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol 2002; 45:1095-106.
18. Haak-Frendscho M, Czuprynski CJ. Use of recombinant interleukin-2 to enhanced adoptive transfer of resistance to Listeria monocytogenes infection. Infect Immun 1992; 60:1406-14.
19. + T cell response during Listeria monocytogene infection. J Immunol 2002; 168:6382-7.
20. Marzo AL, Vezys V, Williams K, Tough DF, Lefrancois L. Tissue-level regulation of Th1 and Th2 primary and memory CD4 T cells in response to Listeria infection. J Immunol 2002; 168:4504-10.
21. Wing EJ, Gregory SH. Listeria monocytogenes: clinical and experimental update. J Infect Dis 2002; 185(Suppl 1):S18-24.
22. Hantel A, Dick JD, Karp JE. Listeriosis in the setting of malignant disease: changing issues in an unusual infection. Cancer 1989; 64:516-20.
23. Amini RM, Glimelius B, Gustavsson A, et al. A population-based study of outcome for patients with first relapse of Hodgkin's lymphoma. Eur J Haematol 2002; 68:225-32.
24. Lavon I, Goldberg I, Amit S, et al. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat Med 2000; 6:573-7.
25. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191-202.
26. Barsig J, Flesch IE, Kaufmann SH. Macrophages and hepocytic cells as chemokine producers in murine listeriosis. Immunobiology 1998; 199:87-104.
27. Nolla-Salas J, Almela M, Gasser I, Latorre C, Salvado M, Coll P. Spontaneous Listeria monocytogenes peritonitis: a population-based study of 13 cases collected in Spain. Am J Gastroenterol 2002; 97:1507-11.
28. Crum NF. Update on Listeria monocytogenes infection. Curr Gastroenterol Rep 2002; 4:287-96.
29. Safdar A, Armstrong D. Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997). J Clin Microbiol 2003; 41:483-5.
30. Arsene O, Linassier C, Quentin R, Legras A, Colombat P. Development of listeriosis during vancomycin therapy in a neutropenic patient. Scand J Infect Dis 1996; 28:415-6.
31. Prats N, Lopez S, Domingo M, et al. Prolonged persistence of Listeria monocytogenes after intragastric infection in corticosteroid-treated mice. Vet Microbiol 1997; 58:79-85.
32. Cao L, Lawrence DA. Suppression of host resistance to Listeria monocytogenes by acute cold/restraint stress: lack of direct IL-6 involvement. J Neuroimmunol 2002; 133:132-43.
33. Keil D, Luebke RW, Pruett SB. Quantifying the relationship between multiple immunological parameters and host resistance: probing the limits of reductionism. J Immunol 2001; 167:4543-52.
34. Centers for Disease Control and Prevention. Multistate outbreak of listeriosis - United States, 1998. MMWR Morb Mortal Wkly Rep 1998; 47:1085-6.